Literature DB >> 22859693

Childhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions.

Claire N Ashley1, Kelly D Hoang, David R Lynch, Susan L Perlman, Bernard L Maria.   

Abstract

Childhood ataxia is characterized by impaired balance and coordination primarily because of cerebellar dysfunction. Friedreich ataxia, a form of childhood ataxia, is the most common multisystem autosomal recessive disease. Most of these patients are homozygous for the GAA repeat expansion located on the first intron of the frataxin gene on chromosome 9. Mutations in the frataxin gene impair mitochondrial function, increase reactive oxygen species, and trigger redistribution of iron in the mitochondria and cytosol. Targeted therapies for Friedreich ataxia are undergoing testing. In addition, a centralized database, patient registry, and natural history study have been launched to support clinical trials in Friedreich ataxia. The 2011 Neurobiology of Disease in Children symposium, held in conjunction with the 40th annual Child Neurology Society meeting, aimed to (1) describe clinical features surrounding Friedreich ataxia, including cardiomyopathy and genetics; (2) discuss recent advances in the understanding of the pathogenesis of Friedreich ataxia and developments of clinical trials; (3) review new investigations of characteristic symptoms; and (4) establish clinical and biochemical overlaps in neurodegenerative diseases and possible directions for future basic, translational, and clinical studies.

Entities:  

Mesh:

Year:  2012        PMID: 22859693      PMCID: PMC3695710          DOI: 10.1177/0883073812448840

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  36 in total

1.  Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex.

Authors:  Chi-Lin Tsai; David P Barondeau
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

2.  Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability.

Authors:  Sherman Ku; Elisabetta Soragni; Erica Campau; Elizabeth A Thomas; Gulsah Altun; Louise C Laurent; Jeanne F Loring; Marek Napierala; Joel M Gottesfeld
Journal:  Cell Stem Cell       Date:  2010-11-05       Impact factor: 24.633

Review 3.  Clinical impact of left ventricular hypertrophy and implications for regression.

Authors:  Surya M Artham; Carl J Lavie; Richard V Milani; Dharmendrakumar A Patel; Anil Verma; Hector O Ventura
Journal:  Prog Cardiovasc Dis       Date:  2009 Sep-Oct       Impact factor: 8.194

4.  Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia.

Authors:  Bart E Drinkard; Randall E Keyser; Scott M Paul; Ross Arena; Jonathan F Plehn; Jack A Yanovski; Nicholas A Di Prospero
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

5.  A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.

Authors:  David R Lynch; Susan L Perlman; Thomas Meier
Journal:  Arch Neurol       Date:  2010-08

6.  Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases.

Authors:  C James Chou; David Herman; Joel M Gottesfeld
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

7.  Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing.

Authors:  Chunping Xu; Elisabetta Soragni; C James Chou; David Herman; Heather L Plasterer; James R Rusche; Joel M Gottesfeld
Journal:  Chem Biol       Date:  2009-09-25

8.  Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.

Authors:  Giovanni Coppola; Daniele Marmolino; Daning Lu; Qing Wang; Miriam Cnop; Myriam Rai; Fabio Acquaviva; Sergio Cocozza; Massimo Pandolfo; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2009-04-17       Impact factor: 6.150

9.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

10.  Intensive coordinative training improves motor performance in degenerative cerebellar disease.

Authors:  W Ilg; M Synofzik; D Brötz; S Burkard; M A Giese; L Schöls
Journal:  Neurology       Date:  2009-10-28       Impact factor: 9.910

View more
  3 in total

Review 1.  Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors:  Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-12-26

2.  A Mild Form of COG5 Defect Showing Early-Childhood-Onset Friedreich's-Ataxia-Like Phenotypes with Isolated Cerebellar Atrophy.

Authors:  Young Ok Kim; Misun Yun; Jae Ho Jeong; Seong Min Choi; Seul Kee Kim; Woong Yoon; Chungoo Park; Yeongjin Hong; Young Jong Woo
Journal:  J Korean Med Sci       Date:  2017-11       Impact factor: 2.153

Review 3.  Heart disease in Friedreich's ataxia.

Authors:  Emily Hanson; Mark Sheldon; Brenda Pacheco; Mohammed Alkubeysi; Veena Raizada
Journal:  World J Cardiol       Date:  2019-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.